Viewing Study NCT03961932

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2025-12-28 @ 4:46 AM
Study NCT ID: NCT03961932
Status: COMPLETED
Last Update Posted: 2020-03-05
First Post: 2019-05-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function
Sponsor: ObsEva SA
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Impairment View
None Healthy Participants View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Linzagolix View
None OBE2109 View
None Renal impairment View
None Renal Insufficiency View
None Kidney Diseases View
None Clinical pharmacology study View